We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

120 hedge funds and large institutions have $654M invested in Cardiovascular Systems, Inc. in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 45 increasing their positions, 41 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more call options, than puts

Call options by funds: $1.21M | Put options by funds: $890K

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

10% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 41

3% more capital invested

Capital invested by funds: $634M → $654M (+$20.1M)

8% less funds holding

Funds holding: 131120 (-11)

38% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 29

Holders
120
Holders Change
-11
Holders Change %
-8.4%
% of All Funds
3.45%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
18
Increased
45
Reduced
41
Closed
29
Calls
$1.21M
Puts
$890K
Net Calls
+$315K
Net Calls Change
-$2.19M
Name Holding Trade Value Shares
Change
Change in
Stake
CM
26
Castleark Management
Illinois
$6.48M -$1.48M -51,266 -20%
O
27
OrbiMed
New York
$6.42M +$5.94M +206,000 New
CPIM
28
Columbia Partners Investment Management
Virginia
$6.35M -$9.58M -332,183 -62%
RFC
29
Russell Frank Company
Washington
$6M +$850K +29,496 +15%
EIM
30
Essex Investment Management
Massachusetts
$6M -$1.03M -35,593 -16%
Millennium Management
31
Millennium Management
New York
$5.67M -$1.48M -51,288 -22%
Ohio Public Employees Retirement System (OPERS)
32
Ohio Public Employees Retirement System (OPERS)
Ohio
$5.26M
Geode Capital Management
33
Geode Capital Management
Massachusetts
$5.15M +$348K +12,056 +8%
Lord, Abbett & Co
34
Lord, Abbett & Co
New Jersey
$4.84M -$2.57M -88,997 -36%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$4.84M -$55.8K -1,935 -1%
OM
36
Opaleye Management
Massachusetts
$4.21M
PCM
37
Perkins Capital Management
Minnesota
$4.05M -$104K -3,600 -3%
Ameriprise
38
Ameriprise
Minnesota
$3.98M +$94K +3,259 +3%
TCIM
39
TIAA CREF Investment Management
New York
$3.78M +$456K +15,821 +15%
HM
40
HealthCor Management
New York
$3.25M +$617K +21,400 +26%
TI
41
Turner Investments
Pennsylvania
$3.12M +$1.35M +46,810 +88%
DIA
42
Denver Investment Advisors
Colorado
$3.06M +$1.08M +37,501 +62%
SC
43
Sophrosyne Capital
New York
$2.9M +$1.33M +46,300 +99%
ACM
44
Apex Capital Management
Ohio
$2.82M +$360K +12,496 +16%
TA
45
Teton Advisors
New York
$2.78M
WA
46
WFG Advisors
Texas
$2.73M +$25.4K +880 +1%
TCM
47
Timpani Capital Management
Wisconsin
$2.54M +$1.16M +40,149 +97%
BIM
48
BlackRock Investment Management
Delaware
$2.49M +$214K +7,438 +10%
Charles Schwab
49
Charles Schwab
California
$2.16M +$138K +4,802 +7%
AQR Capital Management
50
AQR Capital Management
Connecticut
$1.86M -$784K -27,200 -31%

CSII Hedge Fund Activity: Q2 2014 in Review

120 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q2 2014, worth a combined $654M — up 3.2% from $634M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of CSII and 18 opened new positions — a net loss of 11 holders — while 41 trimmed existing stakes and 45 added.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $46.9M. The largest seller was Columbia Partners Investment Management, cutting an estimated $9.58M.

  • 120 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q2 2014, down from 131 in Q1 2014.
  • Funds reported $654M of Cardiovascular Systems, Inc. stock for Q2 2014, up 3.2% quarter-over-quarter.
  • 18 funds opened new Cardiovascular Systems, Inc. positions in Q2 2014 and 29 closed out, a net change of -11 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q2 2014 was Consonance Capital Management, an estimated $46.9M added.
  • The largest Cardiovascular Systems, Inc. seller in Q2 2014 was Columbia Partners Investment Management, an estimated $9.58M sold.

Based on aggregated 13F filings for Q2 2014.